Investors forum

Hosted by Johnson & Johnson Innovation

The Investors forum is an exciting opportunity for those young companies (< 5 years) looking for equity capital and/or partnerships with companies and institutes across the life sciences value chain, from biotech, medtech and pharma companies to financiers and universities. The forum offers excellent opportunities for presenting your company to Venture Capitalists, corporate- and regional investment funds and to discuss your business strategy.

Participate in the Investors Forum and grab your chance to meet with interesting partners, initiate strategic alliances or tap into the international financing networks.

Participating investors 
The Investors Forum enables you to evaluate new investment opportunities and to meet with the management of the most promising life sciences companies, start-ups as well as established ventures. After the forum there will be ample opportunity to further discuss future collaborations in one-on-one meetings.

Investors present:

• BioGeneration Ventures
• BOM Brabant Ventures
• Curie Capital 3 BV
• FIRST Fund
• Forbion
• Inkef
• Janssen Pharmaceutical
• Libertatis Ergo Holding
• Nextgen Ventures
• Novo Holdings
• Oost NL
• ROM Utrecht Region
• Thuja Capital

Presenting companies
Prior to the event, companies will be invited to participate in a number of dry-run presentations. The Investors Forum committee will provide feedback and give advice. The winner of the Investors Forum will be awarded the ´Investors Forum prize´, a partnering ticket with a total value of EUR 2,500 and will be allowed to repeat the winning pitch in the plenary programme. Upon registration you will be given further details.

Selected pitching companies: 

• BIMINI Biotech > Oncology drug development
• BeephoniX > Medical device
• Cell4pharma BB> Cell line screening services
• InnoFluidics > Cell analysis platform
• Levels Diagnostics > Diagnostics
• NatInLab B.V. > Bio Pharmaceutical
• QurieGen > Data-driven drug discovery services
• RiboPro > RNA therapeutics
• River BioMedics > Small molecule drug development for cardiac diseases
• Simmunext Biotherapeutics BV > Immunotherapy
• Spatium Medical > Medical device
• SurvivX > Parasite therapy development
• UPyTher > Drug delivery

General information and registration 
The Investors Forum is open to representatives of pharma and biotech companies (manufacturing, service providers and research & development) younger than 5 years, investors and technology transfer departments at universities. Participation will be reviewed by the Investors Forum Committee and is on a first-come, first-served basis. The Investors Forum may be sold out.
During the conference the forum will be held in two sessions:

• Part 1 - breakfast session (08:00 - 09:00)
• Part 2 - lunch session (12:45 - 13:30)

This will enable participants to attend the complete programme of the conference as well. Participation in the Investors Forum involves no additional costs. Conference registration is all that is required. If you are interested in participating in the Investors Forum, please contact Miranda de Regt at miranda.de.regt@dutchlifesciences.com.